Abstract
Introduction: The only causal therapy in ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (rtPA), but it is feasible only for few patients, and new therapies are needed. This study investigates the effects of systemic thrombolysis with rtPA combined with hyperbaric oxygen therapy (HBOT) in embolic stroke in rats.
Methods: In 22 male Wistar rats, an embolic ischemic stroke was induced. The animals were randomized to one of four groups: control, thrombolysis alone, HBOT sequential or HBOT parallel with thrombolysis. HBOT (2.4 ATA, 1 h) started 45 min (sequential) or 120 min (parallel) after stroke. rtPA was given intravenously 120 min after stroke onset. Functional tests were performed after stroke induction and after treatment. After 6 h infarct volume and intracerebral hemorrhagic complications were assessed.
Results: Compared to the control group only the combination of HBOT and thrombolysis significantly improved the functional outcome (p = 0.03) and reduced the infarct volume (p = 0.01), whereas thrombolysis alone did not show a significant benefit. In all treatment groups there was a trend towards fewer hemorrhagic transformations.
Conclusion: Hyperbaric oxygen in combination with thrombolysis shows neuroprotection in acute ischemic stroke in rats by reducing infarct volume and improving functional outcome in the early poststroke period.
Equally contributed
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rockswold GL, Loewenson RB (1991) A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke 22:1137–1142
Brinker G, Pillekamp F, Hossmann KA (1999) Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats. NeuroReport 10(9):1943–1946
Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC (2000) Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31(8):1812–1816
Fisher M (2004) The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis 17(Suppl):1–6
Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA (2003) Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. Neurol Res 25(4):377–382
Gerriets T, Postert T, Goertler M, Stolz E, Schlachetzki F, Sliwka U, Seidel G, Weber S, Kaps M (2000) DIAS I: duplex-sonographic assessment of the cerebrovascular status in acute stroke. A useful tool for future stroke trials. Stroke 31:2342–2345
Günther A, Küppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, Rossner S (2005) Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci 21(11):3189–3194
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329
Henninger N, Küppers-Tiedt L, Sicard KM, Günther A, Schneider D, Schwab S (2006) Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp Neurol 201(2):316–323
Kerenyi L, Kardos L, Szász J, Szatmári S, Bereczki D, Hegedüs K, Csiba L (2006) Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison. Eur J Neurol 13:1251–1255
Khaja AM, Grotta JC (2007) Established treatments for acute ischaemic stroke. Lancet 369:319–330
Larrue V, von Kummer R, del Zoppo G, Bluhmki E (1997) Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28:957–960
Menzies SA, Hoff JT, Betz AL (1992) Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31(1):100–106; discussion 106–107
Mink RB, Dutka AJ (1995) Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke 26(12):2307–2312
Niessen F, Hilger T, Hoehn M, Hossmann KA (2003) Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 34:2019–2024
Nighoghossian N, Trouillas P, Adeleine P, Salord F (1995) Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke 26:1369–1372
NINDS rt-PA Stroke Study Group (1997) Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. Stroke 28:2109–2118
Quinn TJ, Dawson J, Lees KR (2008) Past, present and future of alteplase for acute ischemic stroke. Expert Rev Neurother 8(2):181–192
Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G (2007) Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 38(4):1362–1367
Rusyniak DE, Kirk MA, May JD, Kao LW, Brizendine EJ, Welch JL, Cordell WH, Alonso RJ (2003) Hyperbaric oxygen therapy in acute ischemic stroke: results of the hyperbaric oxygen in acute ischemic stroke trial pilot study. Stroke 34:571–574
Schabitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, Muller H, Carl U, Toyokuni S, Sommer C, Schwab S (2004) Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke 35:1175–1179
Schatlo B, Henning EC, Pluta RM, Latour LL, Golpayegani N, Merrill MJ, Lewin N, Chen Y, Oldfield EH (2008) Nitrite does not provide additional protection to thrombolysis in a rat model of stroke with delayed reperfusion. J Cereb Blood Flow Metab 28(3):482–489
Veltkamp R, Warner DS, Domoki F, Brinkhous AD, Toole JF, Busija DW (2000) Hyperbaric oxygen decreases infarct size and behavioural deficit after transient focal cerebral ischemia in rats. Brain Res 853:68–73
Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, Nagel S, Schwab S, Schwaninger M (2005) Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 36:1679–1683
Walters MR, Muir KW, Harbison J, Lees KR, Ford GA (2005) Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis 20(6):438–442
Yin D, Zhou C, Kusaka I, Calvert JW, Parent AD, Nanda A, Zhang JH (2003) Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab 23:855–864
Yin D, Zhang JH (2005) Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Neurocrit Care 2(2):206–211
Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR (1997) A rat model of focal embolic cerebral ischemia. Brain Res 766(1–2):83–92
Zhang RL, Chopp M, Zhang ZG, Divine G (1998) Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats. J Neurol Sci 160(1):1–8
Zhang JH, Singhal AB, Toole JF (2003) Oxygen therapy in ischemic stroke. Stroke 34:152–153
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag/Wien
About this chapter
Cite this chapter
Küppers-Tiedt, L. et al. (2011). Combined Systemic Thrombolysis with Alteplase and Early Hyperbaric Oxygen Therapy in Experimental Embolic Stroke in Rats: Relationship to Functional Outcome and Reduction of Structural Damage. In: Zhang, J., Colohan, A. (eds) Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum, vol 111. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0693-8_28
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0693-8_28
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0692-1
Online ISBN: 978-3-7091-0693-8
eBook Packages: MedicineMedicine (R0)